Prevention and Treatment of AIDS-IV

A.Tevfik CENGİZ; Lügen CENGİZ; Mehmet KIYAN; Muzaffer GÖZ; G.İştar DOLAPÇI; Meltem TIBET

doi:10.58600/eurjther.19920301-1267

Authors

A.Tevfik CENGİZ Ankara Ü., Tıp Fakültesi Mikrobiyoloji ABD.Prof.Dr.
Lügen CENGİZ Ankara Ü., Tıp Fakültesi Kadın Hast.ve Doğum ABD.Prof.Dr.
Mehmet KIYAN Ankara Ü., Tıp Fakültesi Mikrobiyoloji ABD.Yrd.Doç.Dr.
Muzaffer GÖZ Ankara Ü., Tıp Fakültesi Mikrobiyoloji ABD.Arş.Gör.
G.İştar DOLAPÇI Ankara Ü., Tıp Fakültesi Mikrobiyoloji ABD.Arş.Gör.
Meltem TIBET Ankara Ü., Tıp Fakültesi Mikrobiyoloji ABD.Arş.Gör.

DOI:

https://doi.org/10.58600/eurjther.19920301-1267

Keywords:

HIV, AIDS, Korunma, Tedavi

Abstract

In this article principles of prevention and treatınent was explained for AIDS which has been an important and current health problem. At the same time, the other side of this subject, the importance of AIDS both for mother and infant is emphasized the behavior male and female patients with AIDS was dwelled on and activity of antiviral agents like AZT,ddc,ddı,suramine, interferon and ribavirine, was reviewed.

Metrics

Metrics Loading ...

References

Anzen B., Lidrnan K., Jörbeck H.: HIV infection and pregnancy. Scand J Ifect Dis (supp) 7D:73, 1990.

Jovaisas E., Koch MA., Seha fer A., Stauber M., Löwenthal D.: LAV/HTLV-III in 20 week fetus (Letter). Lancet 2:1129, 1985.

Spencer S., Soumernko FFS., Puissant F., et al: Vertical transmission of HIV in 15 week fetus. Lancet 2:288, 1986.

Scott GB., Fischl MA., Klimas w.; et al: Mothers to infants with the acquired immunodeficiency syndrome- Ey idence for both symptomatic and asymptomatic carriers. JAMA 253:363, 1985.

Marion RW., Wisnia AA., Hutchcon G., et al: Human T-cell lymphotrophic virus type II (HTLV-III) embryopathy. Am J Dis Child 140:638, 1986.

Rogers MF., Ewing EP., Navfield D., et al: Virologic studies of HTLV-III/LAV in pregnancy. Case report of the woman with AIDS. Obstet Gynecol 68:25, 1986.

Menez-Bantista B., Fikrig SM., Pahwa S., et al: Monozygotic twins discordant for the acquired immunodeficiency syndrome. Am J Dis Child 140:678, 1986.

Ziegler JB., Cooper DA., Johnson RO., et al: Postnatal transmission of AIDS-associated retrovirus from mother to infant. Lancet 1:896, 1985.

Lepage P., Van de Perre P., Carael M., et al: Postnatal transmission of HIV from mother to child. Lancet ii:400, 1987.

The European Collaborative Study: Mother to Child transmission of HIV infection. Lancet ii:1034, 1988.

Halian multicentre study: Epidemiology clinical features and prognostic factors of pediatric HIV infection. Lancet ii:1043-1988.

Minkoff H., Nanda P., Menez R., et al: Pregnancies resulting in infats with acquired immunodeficiency syndrome or AIDS related complex:follow-up of mothers, children and subsequently bom siblings. Obstet Gynecol 69:288, 1987.

Forsgren M., Lidman k., Von Sydow M., et al: HIV-infection hos gravida kvinnor och deras bam. Lakartidningen 85:2270, 1988.

Weinberg ED.: Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 6:814, 1984.

Biggar RJ., Pahwa 5., et al: Helper and supressor lymphocyte changes in HIV infected mothers and their infants. Abstract 4031.IV th. İnternational Conference on AIDS. Stockholm, 1988.

Selwyn P., Schuenbaum E., Davenny K., et al: Prospective study of human irnmunodeficiency virus infection and pregnancy outcomes in intravenous drugusers. JAMA 261:1289, 1988.

Barnett MA., Learmonth RP., Pihl E., et al: T helper lymphocyte depression in early human pregnancy. J Reprod Immunol 5:55, 1983.

Mc Danough RJ., Madden JJ., Falek A., et al: Alternative of T and null lymphocyte frequencies in the perihepheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol 125:2539, 1980.

Morse JH.: The effect of human chorionic gonadotropin and placental lactogen on lymphocyte transformation in vitro. Scand J Immunol 5:779, 1976.

Sites DP., Siiteri PK.: Steroids as immunosuppressants in pregnancy. Immunol Rev 75:117, 1983.

Stimson WH.: In Wegmann TG and Gill TJ (eds): Immunology of reproduction. New York, Oxford University Press, 1983.p:283.

Krause PJ., Ingradia GJ., Pontius LT: Host defence during pregnancy:Neutrophil chemotaxis and adherence. Am J Obstet gynecol 157:274, 1987.

Mobray JF., Underwood JL.: Immunology of abortion. Clin Exp Immunol 60:1, 1985.

Gill TJ., Repetti CF., Metlay LA., et al: Transplancental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 72:987, 1983.

Markovic B., Griziotis G., Nicholls EM.: Phagocytosis of maternal lymphocytes by the foetal trophoblast and the immunology of pregnancy. Med Hypoth 10:337, 1983.

Mathur S., Fudenberg HH., Keane M., et al:Fetal cytotoxic antibodies to maternal T lymi,-hocytes:A possible mechanism for maternal tolerance of the fetal allograft. Am J Reprod Immunol 2:23, 1982.

Good RA.: Nutrition and immunity. J Clin Immunol 1:3, 1981.

Gurr MI.: The role of lipids in the regulation of the immune system. Prog. Lipid Res 22:257, 1083.

Hansen MA., Femandes G., Good RA.: Nutrition and irnmunity the influence of diet on autoimmunity and the role of zinc in the human responce. Ann Rev nutr 2:151, 1982.

Punesh RS., Delatuente JC.: Vitamins and immunocompetence. World Rev Nutr Diet 45:97, 1983.

Donohoe RM., Nicholson JKA., Madden JJ., et al: Coordinate and indepent effects of heroin, cocaine and alcohol abuse on T-cell E- rosette formation and antigenic matter expression. Clin Immunol Immunopathol 41: 254, 1986.

Jensen LP., O'Sullivan MJ., Gomez-del Rio M., et al: Acquired immunodeficiency (AIDS) in pregnancy. Am Obstet Gynecol 148:1145, 1984.

Minkoff H., Hayres de Regt R., Landesman S, et al: Pneumocystis carinii pneumonia associated with acquired immunodeficiency syndrome in pregnancy:A report of three maternal deaths. Obstet Gynecol 67:284, 1986.

Nzilambi N., Ryder RW., Behets F., et al: Perinatal HIV transmission in Two African hospitals presented at the third international conference on AIDS. Washington, DC, June 1987.

Church JA., Ailen JR., Stichm ER.: New Scarlet letter(s), pediatric AIDS-Pediatrics 77:423, 1986.

Darrow WW., Jaffe HW., Curran JW.: Fear of AIDS and gonorrhea rates in homosexual men. Lancet 1:159, 1983.

Alter MJ., Frances D.: Evidence of reduced AIDS-associated risk behavior in homosexual/bisexual men but not in heterosexuals or IV drung use in four widely dispersed U.S. countries presented et the third international conference on AIDS-Washington, DC, June 1987.

Brandbeer C.: Women and HIV.BMJ 298:343, 1989.

Conant M., Hardy D., Sematinger J., et al: Condoms prevent transmission of AIDS-associated retrovirus. JAMA 225:1706, 1986.

Hicks DR., Martin LS., Getcheil P., et al: Inactivation of HTLV III/LAV infected cuitures of normal human lymphocytes by nonoxinal-9 in vitro. Lancet ii:1422, 1985.

Feldblum PS., Fortney JA.: Condoms, spermicides and transmission of human immunodeficiency virus:A review of the literature. Am J Public Healt 78:52, 1988.

Böttinger B., Morrelt-Mansson L., Putkonen P., et al: Predictive markers of AIDS a follow-up of lymphocyte subsets and HIV serology in a cohort of patients with lymphoadenopathy. Accepted for publication in Scand J Infect Dis, 1989.

Jörbeck H., Steinkeller E.: Forty-one cases with exposure to HIV-positive blood. Lakartidningen 85:3044, 1988.

Minkoff HL.: Care of pregnant women infected with human immunodeficiency virus. JAMA 258:2714, 1987.

Epstein LG., Sharer LR., Oleske JM., Connor EM., Goudsmit J., Bagdon L., Robert Guraff M., Koenigsberger MR.: Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics 78:678, 1989.

Belman AL., Diamond G., Dickson D., Horovpian D., Liena J., Lantos G., Rubinstein A.: Pediatric acquired immunodeficiency syndrome, Neurologic syndromes. Am J Dis Child 142:29, 1988.

Pyun KH., Ochs HD., Dufford MTW., et al: Perinatal infection with human immunodeficiency virus. N Engl J Med 317:611, 1987.

Miller G., Martin K., Katz BZ., et al: AIDS and antibodies to human immunodeficiency virus (HIV) in children and their families: Clinical experince at yale-New Haven Hospital-Yale J Biol Med 60:527, 1987.

Pizza PA., Eddy J., Falloon J.: Acquired immunodeficiency syndrome in children: Current problems and therapeutic considerations. Am J Med 85:195, 1988.

Pizza PA.: Emerging consepts in treatment of HIV infection in children. JAMA 262:1989, 1989.

Fischl MA., Richman DO., Griecco MH., Gottlieb MS., Volberding PA., Laskin OL., Leedom JM., Groopman JE., Mildvan D., Schooley RT., Jackson GG., Durack OT., King D.: The AZT Collaborative Working Group. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex:A double-blind, placebo-controlled trial. N Engl Med 317:185, 1987.

Yarchoan R., Berg G., Brouwers P., Fischl MA., Spitzer AR., Wichman A., Grafman J., Thomas RV., Safai B., Brunetti A, Pemo CF., Schmidt PJ., Larson SM., Myers CE., Broder S.: Responce of human immunodeficiency virus associated neurological disease to 3'-azido-3'-deoxthymidine. Lancet 1:132, 1987.

Schmitt FA., Bigley JW., McKinnis R., Logue PE., Evans RW., Drucker JL.: The AZT Collaborative Working Group. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 319:1573, 1988.

Pizzo PA., Einloth M., Butler K., Addy J., Jarosinski P., Meer J., FalloonJ., Moss H., Wolters P., Brouwers P., Balis FM., Roplack DG.: A phase I-II study of dideoxycytidine (ddc) alone and in an altemating schedule with AZf in children with symp tomatic HIV infection (Abstract 33). In:Program and abstracts of the 29 th interscience counference on antimicrobial agents and chemotherapy (Houston) Washington, DC: American Society for Microbiology, 1989.

Broder S., et al: Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS- related complex. Lancet 2:627, 1985.

Zagury D., Gagne I., Reveil B., Bemard J., Zagury JF., Saimot EG., Sarin PS., Gallo R.: Repairing the T-cell defect in AIDS. Lancet 2:449, 1985.

Ho DD., Rota TR., Kaplan JC., Hartshom KL., Andrews CA., Schooley RT., Hirsch MS.: Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet 1:602, 1985.

Rouvroy D., et al: Suramin for AIDS. Lancet 1:878, 1895.

Mc Cormic JB., Getchell JP., Mitchel SW., et al: Ribavirin suppresses replication of lymphadenopathy- associated virus in culteres of human of adult T-lymphocytes. Lancet 2:1367, 1984.

Mitsuya H., Ropovic M., Yarchoan R., Matsushita S., Gallo RC., et al: Suramin protection of T-cells in vitro against infectivity and cytopathic effect of HTLV-III. Science 226:174, 1984.

Sorin PS., Gallo RC., Scheer Dl., et al: Effects of a novel compound (AL 721) on HTLV-III infectivity in vitro. N Engl J Med 313:1289, 1985.